BSE filing, NSE: SWASTIKA. Summary written from the filing by ALFA Finder's alert engine.
Swastika Investmart Ltd: key numbers
- Share price
- ₹123.55
- Market cap
- ₹213.9 Cr
- Revenue (annual)
- ₹109.7 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 13.8×Sector 19.5×
- Promoter holding
- 59.88%+0.00% QoQ
- FII holding
- 0.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Swastika Investmart Ltd
All →Swastika Investmart Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 57.6% YoY
Swastika Investmart Ltd reported revenue from operations of ₹29.5 Cr (+5.7% YoY) and net profit of ₹5.2 Cr (+57.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +57.6% YoY
Swastika Investmart Employee Stock Options
Swastika Investmart granted 5,000 employee stock options to eligible employees under its ESOS 2025 scheme. Each option is convertible into one equity share.
Swastika Investmart Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b). The notes disclose details on inter-se promoter transfers, ESOP grants, and outstanding share warrants.
Swastika Investmart Board Meeting Date
Swastika Investmart Limited scheduled a board meeting on October 21, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending September 2026.
Swastika Investmart Capital Structure Change
Swastika Investmart Limited announced that its previously allotted 90,50,000 convertible equity share warrants will now trade under the new ISIN INE691C13027.
Swastika Investmart Capital Structure Change
Swastika Investmart Limited allotted 90,50,000 convertible share warrants on a preferential basis. The company received an upfront payment of ₹14.40 Crore, representing 25% of the total consideration.
- Value
- ₹14.40 Cr
- Execution
- 18 months
Other management change announcements
All →Jivial Industries Management Change
Jivial Industries appointed Shivam Dineshbhai Sakariya as Additional Non-Executive Independent Director effective 5 November 2026. The NRC recommended the appointment.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Texmaco Rail & Engineering Management Change
Texmaco Rail & Engineering has re-appointed Mr. Udyavar Vittal Kamath as an Executive Director (WTD) with effect from 1 February 2027 for a 12-month term. The filing is a Regulation 30 management change disclosure.
- Execution
- 12 months from 1 February 2027
Windlas Biotech Management Change
Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.
Panasonic Energy India Company Management Change
Panasonic Energy India's Company Secretary and Compliance Officer, Srishti Jain, has resigned effective 30 November 2026. The board accepted the resignation at its 5 November 2026 meeting.
Varvee Global Management Change
Varvee Global's statutory auditor, Pankaj R Shah & Associates, resigned with immediate effect on 5 November 2026, citing preoccupancy with other audit assignments. The filing is a mandatory Regulation 30 auditor-resignation disclosure with no monetary value.